Promethera

Cellaïon

This biotechnology firm develops liver-derived stem cell therapies to treat patients suffering from acute-on-chronic liver failure and severe inflammatory diseases.

Resolution Therapeutics

Resolution Therapeutics develops macrophage cell therapies to treat patients with inflammatory and fibrotic diseases such as end-stage liver disease.

Alder Therapeutics

This company develops allogeneic stem cell therapies to treat patients with retinitis pigmentosa and chronic heart failure.

Promedior

This biotechnology company develops drug therapies to treat rare fibrotic diseases for patients with conditions such as idiopathic pulmonary fibrosis and myelofibrosis.

Akero Therapeutics

This company develops metabolic disease treatments for patients with metabolic dysfunction-associated steatohepatitis and other liver conditions.

Garuda Therapeutics

The company develops off-the-shelf blood stem cell therapies to treat patients with hematologic malignancies, sickle cell disease, and bone marrow failure disorders.

Athersys

Athersys develops regenerative stem cell therapies to treat patients with neurological, inflammatory, and cardiovascular conditions, primarily through its proprietary off-the-shelf MultiStem cell platform.

Clade Therapeutics

This biotechnology company develops stem cell-derived medicines to treat patients with cancer and autoimmune diseases.